Insights on AI-powered clinical data review, trial timeline optimization, and the future of clinical development.
Every day of clinical trial delay costs $40,000 in direct costs and $500,000 in unrealized sales. Manual data review is the most fixable bottleneck. Here's how AI eliminates it.
Read more
Manual clinical trial data review is the single biggest bottleneck in drug development. Learn the 7 specific review bottlenecks adding 8-14 weeks to timelines, and how AI-native review eliminates each one.
Read more
AI anomaly detection in clinical trials replaces manual data review with 99.9% accuracy, traceable flags, and audit-ready transparency. From months to days — audit-ready by design.
Read more
88% of sponsors face five or more weeks of delay in trial reporting and data workflows, with costs ranging from $600,000 to $8 million per day in lost opport...
Read more
Manual SDTM dataset review takes weeks. AI-assisted review takes hours. Here is how ClinAstra replaces pattern-matching with computation, with full audit trail.
Read more
The clinical data review tools market splits into AI-bolted-on assistants and AI-native replacements. Only AI-native tools deliver months-to-days timelines. Here is how to evaluate them.
Read more
Manual clinical data cleaning is the bottleneck nobody questions. AI doesn't speed it up — it replaces it. From months to days with 99.9% accuracy and audit-ready traceability.
Read more
55% of clinical research professionals report burnout. Manual data review — SDTM datasets, edit checks, query management — is the root cause. Here's how AI replaces the grind and saves your team.
Read moreSee how ClinAstra replaces manual clinical data review with AI — 99.9% accuracy, audit-ready, from months to days.
Request a Demo
